T-bet negatively regulates autoimmune myocarditis by suppressing local production of interleukin 17

Journal of Experimental Medicine

Volumn 203, Issue 8, 2006, Pages 2009-2019

  Rangachari, Manu ^a,b   Mauermann, Nora ^c   Marty, René R ^c   Dirnhofer, Stephan ^c   Kurrer, Michael O ^d   Komnenovic, Vukoslav ^a   Penninger, Josef M ^a   Eriksson, Urs ^c  

^a ERICH SCHMID INSTITUTE OF MATERIALS SCIENCE   (Austria)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY HOSPITAL BASEL   (Switzerland)

^d UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 23; TRANSCRIPTION FACTOR T BET;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; CD8+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL LINE; CELL SECRETION; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; GENOTYPE; HEART DISEASE; HELPER CELL; IMMUNIZATION; LYMPHOCYTE; LYMPHOID TISSUE; MOUSE; MYOCARDITIS; NONHUMAN; PATHOGENESIS; POLARIZATION; PRIORITY JOURNAL; TH1 CELL; TH2 CELL;

ANIMALS; ANTIGENS, CD3; AUTOIMMUNE DISEASES; AUTOIMMUNITY; BONE MARROW; CD8-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CYTOKINES; DENDRITIC CELLS; HUMANS; IMMUNIZATION; INTERLEUKIN-17; INTERLEUKIN-23; INTERLEUKIN-23 SUBUNIT P19; INTERLEUKINS; LYMPHOID TISSUE; MICE; MICE, SCID; MYOCARDITIS; MYOCARDIUM; RECEPTORS, INTERLEUKIN-2; T-BOX DOMAIN PROTEINS; T-LYMPHOCYTES, REGULATORY; TH1 CELLS; TH2 CELLS; TRANSCRIPTION FACTORS;

EID: 33746863277     PISSN: 00221007     EISSN: 00221007     Source Type: Journal    
DOI: 10.1084/jem.20052222     Document Type: Article

References (64)

1. Eriksson, U., and J.M. Penninger. 2005. Autoimmune heart failure: new understandings of pathogenesis. Int. J. Biochem. Cell Biol. 37:27-32.
2. Koelsch, S.P.S., G. Hufnagel, and B. Maisch. 2004. The European study of epidemiology and treatment of cardiac inflammatory diseases (ESETCID) - epidemiological results after 6 years. In Annual Meeting of the AHA, New Orleans.
3. Caforio, A.L., E. Bonifacio, J.T. Stewart, D. Neglia, O. Parodi, G.F. Bottazzo, and W.J. McKenna. 1990. Novel organ-specific circulating cardiac autoantibodies in dilated cardiomyopathy. J. Am. Coll. Cardiol. 15:1527-1534.
4. Frustaci, A., C. Chimenti, F. Calabrese, M. Pieroni, G. Thiene, and A. Maseri. 2003. Immunosuppressive therapy for active lymphocytic myocarditis: virological and immunologic profile of responders versus nonresponders. Circulation. 107:857-863.
5. Omerovic, E., E. Bollano, B. Andersson, V. Kujacic, W. Schulze, A. Hjalmarson, F. Waagstein, and M. Fu. 2000. Induction of cardiomyopathy in severe combined immunodeficiency mice by transfer of lymphocytes from patients with idiopathic dilated cardiomyopathy. Autoimmunity. 32:271-280.
6. Fairweather, D., Z. Kaya, G.R. Shellam, C.M. Lawson, and N.R. Rose. 2001. From infection to autoimmunity. J. Autoimmun. 16:175-186.
7. Eriksson, U., R. Ricci, L. Hunziker, M.O. Kurrer, G.Y. Oudit, T.H. Watts, I. Sonderegger, K. Bachmaier, M. Kopf, and J.M. Penninger. 2003. Dendritic cell-induced autoimmune heart failure requires cooperation between adaptive and innate immunity. Nat. Med. 9:1484-1490.
8. Bachmaier, K., N. Neu, L.M. de la Maza, S. Pal, A. Hessel, and J.M. Penninger. 1999. Chlamydia infections and heart disease linked through antigenic mimicry. Science. 283:1335-1339.
9. Nicholson, L.B., and V.K. Kuchroo. 1996. Manipulation of the Th1/Th2 balance in autoimmune disease. Curr. Opin. Immunol. 8:837-842.
10. Eriksson, U., M.O. Kurrer, W. Sebald, F. Brombacher, and M. Kopf. 2001. Dual role of the IL-12/IFN-gamma axis in the development of autoimmune myocarditis: induction by IL-12 and protection by IFN-gamma. J. Immunol. 167:5464-5469.
11. Afanasyeva, M., Y. Wang, Z. Kaya, E.A. Stafford, K.M. Dohmen, A.A. Sadighi Akha, and N.R. Rose. 2001. Interleukin-12 receptor/STAT4 signaling is required for the development of autoimmune myocarditis in mice by an interferon-gamma-independent pathway. Circulation. 104:3145-3151.
12. Afanasyeva, M., Y. Wang, Z. Kaya, S. Park, M.J. Zilliox, B.H. Schofield, S.L. Hill, and N.R. Rose. 2001. Experimental autoimmune myocarditis in A/J mice is an interleukin-4-dependent disease with a Th2 phenotype. Am. J. Pathol. 159:193-203.
13. Eriksson, U., M.O. Kurrer, R. Bingisser, H.P. Eugster, P. Saremaslani, F. Follath, S. Marsch, and U. Widmer. 2001. Lethal autoimmune myocarditis in interferon-gamma receptor-deficient mice: enhanced disease severity by impaired inducible nitric oxide synthase induction. Circulation. 103:18-21.
14. Rosloniec, E.F., K. Latham, and Y.B. Guedez. 2002. Paradoxical roles of IFN-gamma in models of Th1-mediated autoimmunity. Arthritis Res. 4:333-336.
15. Szabo, S.J., S.T. Kim, G.L. Costa, X. Zhang, C.G. Fathman, and L.H. Glimcher. 2000. A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell. 100:655-669.
16. Szabo, S.J., B.M. Sullivan, C. Stemmann, A.R. Satoskar, B.P. Sleckman, and L.H. Glimcher. 2002. Distinct effects of T-bet in TH1 lineage commitment and IFN-gamma production in CD4 and CD8 T cells. Science. 295:338-342.
17. Bettelli, E., B. Sullivan, S.J. Szabo, R.A. Sobel, L.H. Glimcher, and V.K. Kuchroo. 2004. Loss of T-bet, but not STAT1, prevents the development of experimental autoimmune encephalomyelitis. J. Exp. Med. 200:79-87.
18. Lovett-Racke, A.E., A.E. Rocchini, J. Choy, S.C. Northrop, R.Z. Hussain, R.B. Ratts, D. Sikder, and M.K. Racke. 2004. Silencing T-bet defines a critical role in the differentiation of autoreactive T lymphocytes. Immunity. 21:719-731.
19. Matsuoka, K., N. Inoue, T. Sato, S. Okamoto, T. Hisamatsu, Y. Kishi, A. Sakuraba, O. Hitotsumatsu, H. Ogata, K. Koganei, et al. 2004. T-bet upregulation and subsequent interleukin 12 stimulation are essential for induction of Th1 mediated immunopathology in Crohn's disease. Gut. 53:1303-1308.
20. Juedes, A.E., E. Rodrigo, L. Togher, L.H. Glimcher, and M.G. von Herrath. 2004. T-bet controls autoaggressive CD8 lymphocyte responses in type 1 diabetes. J. Exp. Med. 199:1153-1162.
21. Buono, C., C.J. Binder, G. Stavrakis, J.L. Witztum, L.H. Glimcher, and A.H. Lichtman. 2005. T-bet deficiency reduces atherosclerosis and alters plaque antigen-specific immune responses. Proc. Natl. Acad. Sci. USA. 102:1596-1601.
22. Venkataraman, C., S. Leung, A. Salvekar, H. Mano, and U. Schindler. 1999. Repression of IL-4-induced gene expression by IFN-gamma requires Stat1 activation. J. Immunol. 162:4053-4061.
23. Afanasyeva, M., D. Georgakopoulos, D.F. Belardi, D. Bedja, D. Fairweather, Y. Wang, Z. Kaya, K.L. Gabrielson, E.R. Rodriguez, P. Caturegli, et al. 2005. Impaired up-regulation of CD25 on CD4+ T cells in IFN-gamma knockout mice is associated with progression of myocarditis to heart failure. Proc. Natl. Acad. Sci. USA. 102:180-185.
24. Murphy, K.M., and S.L. Reiner. 2002. The lineage decisions of helper T cells. Nat. Rev. Immunol. 2:933-944.
25. Watford, W.T., M. Moriguchi, A. Morinobu, and J.J. O'Shea. 2003. The biology of IL-12: coordinating innate and adaptive immune responses. Cytokine Growth Factor Rev. 14:361-368.
26. Mullen, A.C., F.A. High, A.S. Hutchins, H.W. Lee, A.V. Villarino, D.M. Livingston, A.L. Kung, N. Cereb, T.P. Yao, S.Y. Yang, and S.L. Reiner. 2001. Role of T-bet in commitment of TH1 cells before IL-12-dependent selection. Science. 292:1907-1910.
27. Afkarian, M., J.R. Sedy, J. Yang, N.G. Jacobson, N. Cereb, S.Y. Yang, T.L. Murphy, and K.M. Murphy. 2002. T-bet is a STAT1-induced regulator of IL-12R expression in naive CD4+ T cells. Nat. Immunol. 3:549-557.
28. Trinchieri, G. 2003. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat. Rev. Immunol. 3:133-146.
29. Aggarwal, S., N. Ghilardi, M.H. Xie, F.J. de Sauvage, and A.L. Gurney. 2003. Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J. Biol. Chem. 278:1910-1914.
30. Harrington, L.E., R.D. Hatton, P.R. Mangan, H. Turner, T.L. Murphy, K.M. Murphy, and C.T. Weaver. 2005. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 6:1123-1132.
31. Happel, K.I., M. Zheng, E. Young, L.J. Quinton, E. Lockhart, A.J. Ramsay, J.E. Shellito, J.R. Schurr, G.J. Bagby, S. Nelson, and J.K. Kolls. 2003. Cutting edge: roles of Toll-like receptor 4 and IL-23 in IL-17 expression in response to Klebsiella pneumoniae infection. J. Immunol. 170:4432-4436.
32. Rutitzky, L.I., J.R. Lopes da Rosa, and M.J. Stadecker. 2005. Severe CD4 T cell-mediated immunopathology in murine schistosomiasis is dependent on IL-12p40 and correlates with high levels of IL-17. J. Immunol. 175:3920-3926.
33. Murphy, C.A., C.L. Langrish, Y. Chen, W. Blumenschein, T. McClanahan, R.A. Kastelein, J.D. Sedgwick, and D.J. Cua. 2003. Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. J. Exp. Med. 198:1951-1957.
34. Langrish, C.L., Y. Chen, W.M. Blumenschein, J. Mattson, B. Basham, J.D. Sedgwick, T. McClanahan, R.A. Kastelein, and D.J. Cua. 2005. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med. 201:233-240.
35. Park, H., Z. Li, X.O. Yang, S.H. Chang, R. Nurieva, Y.H. Wang, Y. Wang, L. Hood, Z. Zhu, Q. Tian, and C. Dong. 2005. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 6:1133-1141.
36. McKenzie, B.S., R.A. Kastelein, and D.J. Cua. 2006. Understanding the IL-23-IL-17 immune pathway. Trends Immunol. 27:17-23.
37. Lugo-Villarino, G., R. Maldonado-Lopez, R. Possemato, C. Penaranda, and L.H. Glimcher. 2003. T-bet is required for optimal production of IFN-gamma and antigen-specific T cell activation by dendritic cells. Proc. Natl. Acad. Sci. USA. 100:7749-7754.
38. Lighvani, A.A., D.M. Frucht, D. Jankovic, H. Yamane, J. Aliberti, B.D. Hissong, B.V. Nguyen, M. Gadina, A. Sher, W.E. Paul, and J.J. O'Shea. 2001. T-bet is rapidly induced by interferon-gamma in lymphoid and myeloid cells. Proc. Natl. Acad. Sci. USA. 98:15137-15142.
39. Rangachari, M., U. Eriksson, E.H. Vollmann, and J.M. Penninger. 2005. A novel model for pathogenesis of autoimmune heart failure: the role of dendritic cells. In The Innate Immune System: Strategies for Disease Control, 1285. M. Taniguchi, S. Akira, and T. Nakayama, editors. International Congress Series, Netherlands. 192-201.
40. Gavin, M., and A. Rudensky. 2003. Control of immune homeostasis by naturally arising regulatory CD4+ T cells. Curr. Opin. Immunol. 15:690-696.
41. Sullivan, B.M., A. Juedes, S.J. Szabo, M. von Herrath, and L.H. Glimcher. 2003. Antigen-driven effector CD8 T cell function regulated by T-bet. Proc. Natl. Acad. Sci. USA. 100:15818-15823.
42. Penninger, J.M., N. Neu, E. Timms, V.A. Wallace, D.R. Koh, K. Kishihara, C. Pummerer, and T.W. Mak. 1993. The induction of experimental autoimmune myocarditis in mice lacking CD4 or CD8 molecules. J. Exp. Med. 178:1837-1842.
43. Grabie, N., M.W. Delfs, J.R. Westrich, V.A. Love, G. Stavrakis, F. Ahmad, C.E. Seidman, J.G. Seidman, and A.H. Lichtman. 2003. IL-12 is required for differentiation of pathogenic CD8+ T cell effectors that cause myocarditis. J. Clin. Invest. 111:671-680.
44. Marsland, B.J., N.L. Harris, M. Camberis, M. Kopf, S.M. Hook, and G. Le Gros. 2004. Bystander suppression of allergic airway inflammation by lung resident memory CD8+ T cells. Proc. Natl. Acad. Sci. USA. 101:6116-6121.
45. Haring, J.S., V.P. Badovinac, M.R. Olson, S.M. Varga, and J.T. Harty. 2005. In vivo generation of pathogen-specific Th1 cells in the absence of the IFN-gamma receptor. J. Immunol. 175:3117-3122.
46. Lord, G.M., R.M. Rao, H. Choe, B.M. Sullivan, A.H. Lichtman, F.W. Luscinskas, and L.H. Glimcher. 2005. T-bet is required for optimal proinfl ammatory CD4+ T-cell trafficking. Blood. 106:3432-3439.
47. Neurath, M.F., B. Weigmann, S. Finotto, J. Glickman, E. Nieuwenhuis, H. Iijima, A. Mizoguchi, E. Mizoguchi, J. Mudter, P.R. Galle, et al. 2002. The transcription factor T-bet regulates mucosal T cell activation in experimental colitis and Crohn's disease. J. Exp. Med. 195:1129-1143.
48. Hultgren, O.H., M. Verdrengh, and A. Tarkowski. 2004. T-box transcription-factor-deficient mice display increased joint pathology and failure of infection control during staphylococcal arthritis. Microbes Infect. 6:529-535.
49. Burian, J., P. Buser, and U. Eriksson. 2005. Myocarditis: the immunologist's view on pathogenesis and treatment. Swiss Med. Wkly. 135:359-364.
50. Wynn, T.A. 2005. T(H)-17: a giant step from T(H)1 and T(H)2. Nat. Immunol. 6:1069-1070.
51. Veldhoen, M., R.J. Hocking, C.J. Atkins, R.M. Locksley, and B. Stockinger. 2006. TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity. 24:179-189.
52. Wood, K.J., and B. Sawitzki. 2006. Interferon gamma: a crucial role in the function of induced regulatory T cells in vivo. Trends Immunol. 27:183-187.
53. Kinne, R.W., E. Palombo-Kinne, and F. Emmrich. 1997. T-cells in the pathogenesis of rheumatoid arthritis villains or accomplices? Biochim. Biophys. Acta. 1360:109-141.
54. Pearce, E.L., A.C. Mullen, G.A. Martins, C.M. Krawczyk, A.S. Hutchins, V.P. Zediak, M. Banica, C.B. DiCioccio, D.A. Gross, C.A. Mao, et al. 2003. Control of effector CD8+ T cell function by the transcription factor Eomesodermin. Science. 302:1041-1043.
55. Glimcher, L.H., M.J. Townsend, B.M. Sullivan, and G.M. Lord. 2004. Recent developments in the transcriptional regulation of cytolytic effector cells. Nat. Rev. Immunol. 4:900-911.
56. Tantisira, K.G., E.S. Hwang, B.A. Raby, E.S. Silverman, S.L. Lake, B.G. Richter, S.L. Peng, J.M. Drazen, L.H. Glimcher, and S.T. Weiss. 2004. TBX21: a functional variant predicts improvement in asthma with the use of inhaled corticosteroids. Proc. Natl. Acad. Sci. USA. 101:18099-18104.
57. Akahoshi, M., K. Obara, T. Hirota, A. Matsuda, K. Hasegawa, N. Takahashi, M. Shimizu, K. Nakashima, L. Cheng, S. Doi, et al. 2005. Functional promoter polymorphism in the TBX21 gene associated with aspirin-induced asthma. Hum. Genet. 117:16-26.
58. Raby, B.A., E.S. Hwang, K. Van Steen, K. Tantisira, S. Peng, A. Litonjua, R. Lazarus, C. Giallourakis, J.D. Rioux, D. Sparrow, et al. 2006. T-bet polymorphisms are associated with asthma and airway hyperresponsiveness. Am. J. Respir. Crit. Care Med. 173:64-70.
59. Sengstock, D.M., O. Obeidat, V. Pasnoori, P. Mehra, K.R. Sandberg, and P.A. McCullough. 2002. Asthma, beta-agonists, and development of congestive heart failure: results of the ABCHF study. J. Card. Fail. 8:232-238.
60. Coughlin, S.S., M. Szklo, K. Baughman, and T.A. Pearson. 1989. Idiopathic dilated cardiomyopathy and atopic disease: epidemiologic evidence for an association with asthma. Am. Heart J. 118:768-774.
61. Chinen, J., and W.T. Shearer. 2003. Basic and clinical immunology. J. Allergy Clin. Immunol. 111:S813-S818.
62. Finotto, S., M.F. Neurath, J.N. Glickman, S. Qin, H.A. Lehr, F.H. Green, K. Ackerman, K. Haley, P.R. Galle, S.J. Szabo, et al. 2002. Development of spontaneous airway changes consistent with human asthma in mice lacking T-bet. Science. 295:336-338.
63. Eriksson, U., M.O. Kurrer, N. Schmitz, S.C. Marsch, A. Fontana, H.P. Eugster, and M. Kopf. 2003. Interleukin-6-deficient mice resist development of autoimmune myocarditis associated with impaired upregulation of complement C3. Circulation. 107:320-325.
64. Afanasyeva, M., D. Georgakopoulos, D.F. Belardi, A.C. Ramsundar, J.G. Barin, D.A. Kass, and N.R. Rose. 2004. Quantitative analysis of myocardial inflammation by flow cytometry in murine autoimmune myocarditis: correlation with cardiac function. Am. J. Pathol. 164:807-815.